EUVIMEDEUVIMED entdecken
Crossref

Clinical Course May Be Independent from Neuroimaging in DEPDC-5-Related Epilepsy

Emanuele Bartolini iD, Stefania Della Vecchia, Tommaso Biagioni, Domenico Montanaro, Anna Rita Ferrari

Neuropediatrics · 01.10.2023 · 54 (05) · 347-350

DOI: 10.1055/a-2067-5096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropediatrics, erschienen am 01.10.2023. Verfasst von Emanuele Bartolini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy. Hauptthemen laut MEDLINE: Epilepsy, Epileptic Syndromes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Ministero della Salute, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DEPDC5 is an upstream repressor of the mechanistic target of rapamycin pathway via the GATOR-1 complex. Pathogenic variants causing loss of function typically result in familial focal epilepsy with variable foci. Neuroimaging may either be normal or show brain malformations. Lesional and nonlesional cases may be present within the same family. Here, we describe a parent–child dyad affected by a truncating DEPDC5 pathogenic variant (c.727C > T; p.Arg243*), analyze the epilepsy clinical course, and describe neuroimaging characteristics from a 3T brain magnetic resonance imaging. Despite sharing the same variant, patients diverged both in terms of epilepsy severity and neuroimaging features. Surprisingly, the mother is still suffering from drug-resistant seizures and has normal neuroimaging, while the child has been experiencing prolonged seizure freedom notwithstanding a bottom-of-sulcus focal cortical dysplasia. An increasing gradient of severity has been proposed for families with GATOR1-related epilepsies. We confirm clinical and neuroradiological expressivities are variable and also suggest the prognostication of epilepsy outcome may be particularly difficult. The epilepsy outcome could partially be independent from brain structural abnormalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyEpileptic SyndromesHumansDisease ProgressionGTPase-Activating ProteinsMutationNeuroimaging

Substanzen

GTPase-Activating ProteinsDepdc5 protein, mouse

Autor:innen und Institutionen

  • Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • U.O.s. Dipartimentale e Servizio Autonomo di Risonanza Magnetica, IRCCS Stella Maris Foundation, Pisa, Italy.

ORCID-Profile: Emanuele Bartolini

Förderung

  • Ministero della Salute
  • Italian Ministry of Health

Zitieren

APA

Bartolini, E., Della Vecchia, S., Biagioni, T., Montanaro, D., & Ferrari, A. R. (2023). Clinical Course May Be Independent from Neuroimaging in DEPDC-5-Related Epilepsy. Neuropediatrics, 54(05), 347-350. https://doi.org/10.1055/a-2067-5096

Vancouver

Bartolini E, Della Vecchia S, Biagioni T, Montanaro D, Ferrari AR. Clinical Course May Be Independent from Neuroimaging in DEPDC-5-Related Epilepsy. Neuropediatrics. 2023;54(05):347-350. doi:10.1055/a-2067-5096

BibTeX
@article{Bartolini2023,
  author = {Bartolini, Emanuele and Della Vecchia, Stefania and Biagioni, Tommaso and Montanaro, Domenico and Ferrari, Anna Rita},
  title = {Clinical Course May Be Independent from Neuroimaging in DEPDC-5-Related Epilepsy},
  journal = {Neuropediatrics},
  year = {2023},
  volume = {54},
  number = {05},
  pages = {347--350},
  doi = {10.1055/a-2067-5096}
}
Kostenlos starten →